Clinical Trial

Italian Digital Primary Cardiovascular Prevention Study

Study acronym: CV-PREVITAL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted by the Italian Network of Cardiology (ICN, a cardiovascular research network promoted by the Italian Ministry of Health), in collaboration with the Consorzio Sanità (Co.S., an Italian consortium of general practitioners), CV-PREVITAL aims to develop an innovative model of cardiovascular primary prevention and to validate it in a very large sample of subjects and in 'real life' conditions.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-04-15; most recent amendment 2025-04-01.
Status change: Recruiting → Active, Not Recruiting 2024-04-04
Status change: Not Yet Recruiting → Recruiting 2022-07-12
Trial Details
NCT Number NCT05339841
Lead Sponsor Centro Cardiologico Monzino
Collaborators: Istituto Auxologico Italiano, Humanitas Hospital, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, IRCCS Multimedica, Neuromed IRCCS, IRCCS Policlinico S. Donato, Istituti Clinici Scientifici Maugeri SpA, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Ospedale Policlinico San Martino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Fondazione IRCCS Policlinico San Matteo di Pavia, IRCCS San Raffaele Roma, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions Healthy Population
Enrollment 27,520 participants
Start Date 2022-06-10
Primary Completion 2029-06 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-04